235 related articles for article (PubMed ID: 15722820)
1. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors.
Uchida Y; Minoshima S; Kawata T; Motoori K; Nakano K; Kazama T; Uno T; Okamoto Y; Ito H
Clin Nucl Med; 2005 Mar; 30(3):170-6. PubMed ID: 15722820
[TBL] [Abstract][Full Text] [Related]
2. Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses.
Ozawa N; Okamura T; Koyama K; Nakayama K; Kawabe J; Shiomi S; Yamane H; Inoue Y
Radiat Med; 2006 Jan; 24(1):41-9. PubMed ID: 16715661
[TBL] [Abstract][Full Text] [Related]
3. Warthin's tumor of parotid gland on Tc-99m pertechnetate scintigraphy with lemon juice stimulation: Tc-99m uptake, size, and pathologic correlation.
Miyake H; Matsumoto A; Hori Y; Takeoka H; Kiyosue H; Hori Y; Mori H; Ueyama S; Kashima K
Eur Radiol; 2001; 11(12):2472-8. PubMed ID: 11734943
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors.
Kim BS; Kim SJ; Pak K
Ann Nucl Med; 2016 Jun; 30(5):346-54. PubMed ID: 26897010
[TBL] [Abstract][Full Text] [Related]
5. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions.
Okamura T; Kawabe J; Koyama K; Ochi H; Yamada R; Sakamoto H; Matsuda M; Ohashi Y; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():209-13. PubMed ID: 9879423
[TBL] [Abstract][Full Text] [Related]
6. Four cases of Warthin's tumor of the parotid gland detected with FDG PET.
Horiuchi M; Yasuda S; Shohtsu A; Ide M
Ann Nucl Med; 1998 Feb; 12(1):47-50. PubMed ID: 9559962
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of technetium-99m-pertechnetate scintigraphy with lemon juice stimulation to evaluate Warthin's tumor.
Murata Y; Yamada I; Umehara I; Okada N; Shibuya H
J Nucl Med; 1998 Jan; 39(1):43-6. PubMed ID: 9443737
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of RI scintiscanning to parotid gland tumors].
Shinohara S; Yamamoto E; Tanabe M; Maetani T; Fujiwara K; Kim T
Nihon Jibiinkoka Gakkai Kaiho; 2001 Sep; 104(9):852-8. PubMed ID: 11605225
[TBL] [Abstract][Full Text] [Related]
9. Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters.
Hadiprodjo D; Ryan T; Truong MT; Mercier G; Subramaniam RM
AJR Am J Roentgenol; 2012 Feb; 198(2):W185-90. PubMed ID: 22268210
[TBL] [Abstract][Full Text] [Related]
10. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH
Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography in Warthin's tumor mimicking malignancy impacts the evaluation of head and neck patients.
Rassekh CH; Cost JL; Hogg JP; Hurst MK; Marano GD; Ducatman BS
Am J Otolaryngol; 2015; 36(2):259-63. PubMed ID: 25523505
[TBL] [Abstract][Full Text] [Related]
12. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.
Karaman CZ; Tanyeri A; Özgür R; Öztürk VS
Dentomaxillofac Radiol; 2021 May; 50(4):20200391. PubMed ID: 33237812
[TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration as a diagnostic modality for Warthin tumors identified as fluorodeoxyglucose positron emission tomography/computed tomography-positive.
Kowalewski A; Tissot H; Jehanno N; Bakuła Zalewska E; Choussy O; Lesnik M; Badois N; Rougier G; Klijanienko J
Diagn Cytopathol; 2024 Feb; 52(2):116-122. PubMed ID: 37991130
[TBL] [Abstract][Full Text] [Related]
14. Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?
Kendi AT; Magliocca KR; Corey A; Galt JR; Switchenko J; Wadsworth JT; El-Deiry MW; Schuster DM; Saba NF; Hudgins PA
AJR Am J Roentgenol; 2016 Sep; 207(3):635-40. PubMed ID: 27276388
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.
Khan N; Oriuchi N; Ninomiya H; Higuchi T; Kamada H; Endo K
Ann Nucl Med; 2004 Jul; 18(5):409-17. PubMed ID: 15462403
[TBL] [Abstract][Full Text] [Related]
16. 99mTcO4- accumulation in scintigraphy and expression of Na+/I- symporter in salivary gland tumors.
Akai A; Yamamura Y; Nonaka M; Yoshihara T
Auris Nasus Larynx; 2014 Dec; 41(6):532-8. PubMed ID: 25199743
[TBL] [Abstract][Full Text] [Related]
17. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management.
Basu S; Houseni M; Alavi A
Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of conventional whole-body ¹⁸F-FDG PET/CT in the incidental findings of parotid masses.
Wang HC; Zuo CT; Hua FC; Huang ZM; Tan HB; Zhao J; Guan YH
Ann Nucl Med; 2010 Oct; 24(8):571-7. PubMed ID: 20640540
[TBL] [Abstract][Full Text] [Related]
19. Proliferation PET/CT Imaging of Salivary Gland Tumor.
Minamimoto R
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829412
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of diffusion-weighted MR imaging for differentiating between Warthin's tumor and oncocytoma of the parotid gland.
Kato H; Fujimoto K; Matsuo M; Mizuta K; Aoki M
Jpn J Radiol; 2017 Feb; 35(2):78-85. PubMed ID: 28074380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
